DEVELOPMENT AND VALIDATION OF A TRASTUZUMAB/PERTUZUMAB HYBRID LC-MS ASSAY FOR CLINICAL DEVELOPMENT
Fabrizia Fusetti, Ph.D.
Fabrizia Fusetti, Ph.D. will be making a presentation on Day 2, 18 November 2020 14:30-14:50.
STRATEGIES FOR THE PREVENTION OF NON-SPECIFIC BINDING IN THE QUANTITATIVE DETERMINATION OF DRUGS IN CEREBROSPINAL FLUID
Martijn Hilhorst, Robbert Edens, Bert Ottjes, Benjamin Steenge and Ben van Baar
DEVELOPMENT OF A HYBRID METHOD FOR SIMULTANEOUS QUANTIFICATION OF TWO NEAR IDENTICAL PROTEINS IN PLASMA
Chris Williams, Thomas Fokkinga, Francesco Bonardi, Fabrizia Fusetti and Martijn Hilhorst
NEUROFILAMNENT-LIGHT CHAIN IN MURINE MODELS OF NEURODEGENERATIVE AND RARE DISEASES
Irene Schilcher, Tina Loeffler, Stefanie Flunkert, Birgit Hutter-Paier
INFLAMMASOME ACTIVATION AND REDUCED sTREM2 RELEASE IN LPS STIMULATED ORGANOTYPIC BRAIN SLICES
Irene Schilcher, Tina Loeffler, Stefanie Flunkert, Birgit Hutter-Paier
CORRELATION OF Aβ-pE(3) AND ptau IN HUMAN AND MOUSE BRAIN
Magdalena Temmel1, Joerg Neddens1, Stefanie Flunkert1, Lauren Walker2, Johannes Attems2, Birgit Hutter-Paier1
2Translational and Clinical Research Institute and Newcastle University Institute for Ageing, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK
Neuroinflammation in Mouse Models of Two Different Lysosomal Diseases
Vera Niederkofler, Ewald Auer, Victoria Schiffer, Magdalena Temmel, Joerg Neddens, Birgit Hutter-Paier
SAFETY, TOLERABILITY AND PHARMACODYNAMIC RESULTS OF A FIRST IN HUMAN STUDY WITH THE NEW ANTIPLATELET AGENT ACT017 FOR THE TREATMENT OF THE ACUTE PHASE OS ISCHEMIC STROKE
Christine Voors-Pette1, Peter Dogterom1, Laurie Jullien2, Martine Jandrot-Perrus3, and Gilles Avenard2
A STUDY TO DETERMINE THE POTENTIAL EFFECTS OF DISSOLUTION RATE AND FOOD ON THE PHARMACOKINETICS OF TRIENTINE 2HCL FOLLOWING SINGLE ORAL ADMINISTRATIONS IN HEALTHY SUBJECTS
Peter Dogterom1, Mireille Gerrits2, Khalid Abd-Elaziz1, Daphne van Scheppingen3, Carlot Kruse3
2In2Clinic, Wageningen, The Netherlands
3Univar B.V., Rotterdam, The Netherlands
P1-112: PROGRESSIVE INCREASE OF ALZHEIMER’S DISEASE PATHOLOGY IN 5XFAD TRANSGENIC MICE
Tina Loeffler, Magdalena Temmel, Jörg Neddens, Irene Schilcher, Birgit Hutter-Paier.
P3-113: UNTANGLING ALZHEIMER´S DISEASE HALLMARKS IN SENSORY SYSTEMS OF RODENT MODELS
Joerg Neddens1, Magdalena Temmel1, Meritxell Aguilo Garcia1,2, Tina Loeffler1, Irati Aiestaran Zelaia1, Vera Niederkofler1, Stefanie Flunkert1, Birgit Hutter-Paier1
2Institute of Molecular Biosciences, University of Graz, Graz, Austria
P4-061: TAU PHOSPHORYLATION PROFILE OF HTAU TRANSGENIC MICE
Joerg Neddens, Tina Loeffler, Magdalena Temmel, Irene Schilcher, David Amschl, Birgit Hutter-Paier
P4-062: IN VITRO MODELS TO STUDY TAU AGGREGATION, PHOSPHORYLATION AND UPTAKE
Tina Loeffler, Irene Schilcher, Stefanie Flunkert, Birgit Hutter-Paier